This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Journal of Bone Marrow Transplantation and Cellular Therapy
jbmtct.bsky.social
did:plc:rjbvw7x4inyzrimu7uqdxxsd
A retrospective study evaluated 26 patients with AML or high-risk myelodysplastic syndrome treated with venetoclax-based regimens. Complete remission occurred in 46.1% of cases, with a rapid response & results comparable to international data, despite real-world limitations. https://doi.org/10.46765/2675-374X.2025v7n1e315
2026-03-11T13:32:35.050Z